SCHEMBL6974413

SCHEMBL6974413

O=C(O)C1(c2ccc(Cl)cc2)OCC2(CO1)c1ccccc1Oc1ccccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.37
HTR2A P28223 1/20 0.37
P2RX4 Q99571 3/20 0.36
CCR1 P32246 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.34
TP53 P04637 1/20 0.34
KIF11 P52732 2/20 0.33
CHRNA1 P02708 1/20 0.33
CHRNG P07510 1/20 0.33
CHRNB1 P11230 1/20 0.33
CHRNB2 P17787 1/20 0.33
SLC6A2 P23975 1/20 0.33
CHRNB4 P30926 1/20 0.33
SLC6A4 P31645 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33
SLC6A3 Q01959 1/20 0.33
CHRND Q07001 1/20 0.33
NPSR1 Q6W5P4 2/20 0.33
LMNA P02545 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6971210 0.86 CYP1A2 (0.41) HRH1SMN1; SMN2TP53KIF11SLC6A2
SCHEMBL6982483 0.84 KIF11 (0.44) CCR1SMN1; SMN2TP53KIF11NPSR1
SCHEMBL6967893 0.83 CNR1 (0.40) CNR1MAPK1CES2CES1
SCHEMBL6975804 0.82 OPRM1 (0.41) SMN1; SMN2LMNAHTTMAPK1
SCHEMBL377756 0.81 MAPK1 (0.40) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL6982681 0.76 THRB (0.44) HTR2AKIF11NPSR1HDAC4
SCHEMBL6975695 0.75 POLB (0.38) HRH1HTR2ASLC6A2SLC6A4SLC6A3
SCHEMBL6976918 0.75 HSD11B1 (0.40) LMNAMAPK1HDAC4
SCHEMBL7145811 0.73 APP (0.38) SMN1; SMN2SLC6A4LMNAHTTMAPK1
SCHEMBL6981777 0.73 AKR1C1 (0.41) HTR2ASMN1; SMN2LMNAHTTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098893-B1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6528538-B1 Reaction of 1,3-propanediol derivative with a ketone or aldehyde MERCK PATENTGESELLSCHAFT (DE) 2003-03-04 US disclosed